CLINICAL TRIALS PROFILE FOR NALOXONE HYDROCHLORIDE; OXYCODONE HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for naloxone hydrochloride; oxycodone hydrochloride
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00412100 ↗ | Oxycodone-naloxone Prolonged Release Tablets in Relieving Opioid-related Constipation | Completed | Mundipharma Research GmbH & Co KG | Phase 3 | 2006-04-01 | The primary objective is to demonstrate that patients taking oxycodone/naloxone prolonged release tablets have improvement in symptoms of constipation compared to subjects taking oxycodone prolonged release tablets alone. |
| NCT00412152 ↗ | Oxycodone-naloxone in Relieving Opioid-related Constipation | Completed | Mundipharma Research GmbH & Co KG | Phase 3 | 2006-01-01 | The primary objective of this study is to demonstrate that subjects with moderate to severe non-malignant pain taking oxycodone/naloxone prolonged release tablets have improvement in symptoms of constipation compared to subjects taking oxycodone prolonged release tablets alone. |
| NCT00513656 ↗ | A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer Pain | Completed | Mundipharma Research GmbH & Co KG | Phase 2 | 2007-09-01 | The purpose of this study is to test the oxycodone/naloxone combination compared to oxycodone alone in patient's specific type of "chronic cancer pain". |
| NCT00784810 ↗ | A Study to Compare Oxycodone/Naloxone Prolonged Release Against Codeine/Paracetamol in the Treatment of Moderate to Severe Chronic Low Back Pain or Pain Due to Osteoarthritis | Completed | Napp Pharmaceuticals Limited | Phase 4 | 2009-02-01 | The purpose of this study is to compare oxycodone/naloxone combination tablet and codeine/paracetamol tablets in the treatment of moderate to severe chronic low back pain or pain due to osteoarthritis. |
| NCT00902837 ↗ | OXN PR Compared to OxyPR to Demonstrate Non-inferiority in Pain & Locomotor Function & Improvement in Symptoms of Constipation in OA Subjects | Completed | Mundipharma Research GmbH & Co KG | Phase 3 | 2009-05-01 | The primary objectives are - to demonstrate that the treatment with OXN PR tablets is non-inferior to the treatment with OxyPR with regards to analgesic efficacy and locomotor function. - to demonstrate that subjects with moderate to severe OA pain taking oxycodone/naloxone prolonged release tablets have improvement in symptoms of constipation compared to subjects taking oxycodone prolonged release tablets alone |
| NCT00944697 ↗ | A Study to Demonstrate the Analgesic Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Addition to Pregabalin Compared to Pregabalin Alone in Opioid-naïve Subjects Treated With Pregabalin Suffering From Moderate to Severe Pain Due to Diab | Completed | Mundipharma Research GmbH & Co KG | Phase 2 | 2009-07-01 | To show superior analgesic efficacy of OXN PR in addition to a patient's current dose of pregabalin compared to pregabalin alone. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for naloxone hydrochloride; oxycodone hydrochloride
Condition Name
Clinical Trial Locations for naloxone hydrochloride; oxycodone hydrochloride
Trials by Country
Clinical Trial Progress for naloxone hydrochloride; oxycodone hydrochloride
Clinical Trial Phase
Clinical Trial Sponsors for naloxone hydrochloride; oxycodone hydrochloride
Sponsor Name
